Reef:020/1999 Ref : 31/2020 May 15, 2020 Subject : The explanation of operating results for the first quarter of 2020 To : The SET President Vibhavadi Medical Center Plc. would like to disclose the
Healthcare Center Co.,, Ltd. - a subsidiary of the Company and Wuttisak Clinic Inter Group Co., Ltd. – an indirect subsidiary of E FOR L Aim Public Co., Ltd. had been complete; and further progress shall be
booked in year 2018 for chronic diseases were then subtracted accordingly. However, the service revenues (mainly received from Asia Medical and Agricultural Laboratory and Research Center Co., Ltd “AMARC
Understanding to Invest in Medical Service Business for Healthcare and Esthetics under Trademark “Wuttisak” dated December 22, 2017 Since Filter Vision Public Company Limited (“the Company” or “FVC”) declared to
to the hospital. In regard to the subsidiary, Asia Medical & Agricultural Laboratory and Research Center (“AMARC”), its service revenues grew by 12.60% as it provides laboratory testing and analyzing
LABORATORY AND RESEARCH CENTER PUBLIC COMPANY LIMITED / ASIA MEDICAL AND AGRICULTURAL LABORATORY AND RESEARCH CENTER PUBLIC COMPANY LIMITED Common share IPO CHIN HUAY PUBLIC COMPANY LIMITED / CHIN HUAY
of Thailand The Board of Directors Meeting of Ekachai Medical Care Public Company Limited (EKH) No. 4/2018 held on 12nd November 2018 has passed a resolution to approve for purchase of newly issued
Laboratory and Research Center (“AMARC”), a subsidiary, recorded a 21.02% growth of service revenues totaling Baht 197.75 million over same period of 2018. Costs and Expenses The Company reported 2019
President The Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (EKH) has informed that, according to the Board of Directors meeting No. 4/2019 held on Tuesday 13 August 2019, the Board
” 25 Branches from Total 119 Branches in order to Operate Medical Service Business for Healthcare and Esthetics under Trademark “Wuttisak” (Additional Amendment) Attn. to: President The Stock Exchange of